Live Rare App

In the United States, there is a significant challenge in addressing the diverse and complex needs of individuals affected by rare liver diseases. With over 100 known rare liver diseases, patients and their caregivers face numerous barriers to accessing appropriate information, specialized healthcare, and support networks. The fragmented nature of rare liver diseases exacerbates the difficulties in providing comprehensive care and empowering patients to actively manage their conditions. This lack of centralized resources and tailored support significantly hinders the well-being and quality of life for those affected by rare liver diseases.

Our solution, the Live Rare App, is a comprehensive and patient-centric mobile application designed to address the unique challenges faced by individuals with rare liver diseases. By leveraging advanced technologies and user-friendly features, the Live Rare App aims to empower patients, facilitate access to information, and foster a supportive community.

Key features of the Live Rare App include:

1. Disease Tracking: The app enables users to monitor and track various aspects of their rare liver disease, including symptoms, medication usage, and laboratory results. This allows patients to have a comprehensive overview of their condition and facilitates data sharing with healthcare providers.

2. Personalized Education: The app provides tailored educational resources, including information on specific rare liver diseases, available treatment options, ongoing clinical trials, and self-care strategies. By enhancing health literacy, patients can make informed decisions about their care and actively participate in managing their condition.

3. Community Support: The Live Rare App facilitates connections among patients, caregivers, and healthcare professionals through forums, support groups, and direct communication. This fosters a sense of belonging, enables knowledge sharing, and provides emotional support to individuals affected by rare liver diseases.

4. Rare Liver Disease Database: The app integrates a cloud-based database that securely stores patient data, allowing for anonymized data analysis and research collaborations. By aggregating information from a diverse range of rare liver diseases, the database aims to contribute to scientific advancements, treatment discoveries, and improved patient outcomes.

Our vision is to create a scalable and inclusive platform that can be expanded to encompass other liver diseases, serving as a central hub for individuals and communities facing various liver conditions. Through the Live Rare App, we strive to empower patients, bridge information gaps, and foster a sense of community among those affected by liver diseases, ultimately improving their overall well-being and healthcare outcomes.

Our solution, the Live Rare App, is specifically designed to serve individuals affected by rare liver diseases. This target population includes patients diagnosed with rare liver diseases, their caregivers, and their healthcare providers. We recognize the unique challenges and needs of this population, and our solution aims to directly and meaningfully improve their lives in the following ways:

1. Access to Information: Many individuals affected by rare liver diseases struggle to find accurate and reliable information about their condition. The Live Rare App provides a centralized platform where users can access comprehensive and up-to-date educational resources specific to their rare liver disease. We collaborate with medical experts, patient advocacy groups, and healthcare providers to ensure the information provided is reliable, relevant, and tailored to the unique needs of the users.

2. Empowerment and Self-Management: Rare liver diseases often require individuals to actively manage their condition, including tracking symptoms, medications, and lab results. The Live Rare App offers tools and features that enable users to monitor their disease progression, record and track symptoms, manage medications, and maintain a wellness journal. By empowering individuals with the ability to actively participate in their own care, we aim to enhance their sense of control and improve their overall well-being.

3. Community Support and Engagement: Dealing with a rare liver disease can be isolating. The Live Rare App facilitates connections among individuals within the rare liver disease community through forums, support groups, and direct communication channels. We create a supportive and inclusive environment where users can share experiences, seek advice, and find emotional support. This community engagement is crucial in reducing feelings of isolation and fostering a sense of belonging.

4. Collaboration with Healthcare Providers: The Live Rare App serves as a bridge between patients and their healthcare providers. It enables seamless communication, allowing users to securely share information, ask questions, and receive guidance from their healthcare team. This collaborative approach enhances the patient-provider relationship, promotes effective care coordination, and ensures that treatment plans are tailored to individual needs.

To understand the needs of our target population, we have engaged in extensive research and collaboration with patient advocacy groups, healthcare professionals, and individuals affected by rare liver diseases. We conduct user surveys, interviews, and focus groups to gather insights, feedback, and perspectives directly from the community. These insights inform the development and continuous improvement of the Live Rare App, ensuring that it addresses the specific needs, challenges, and aspirations of the target population.

By serving as a comprehensive and patient-centric solution, the Live Rare App aims to empower individuals affected by rare liver diseases, provide them with accurate information, foster a supportive community, and enhance their ability to actively manage their condition. Ultimately, our goal is to improve the quality of life and healthcare outcomes for this vulnerable population.

As the Peds and Rare Disease Director, I am personally invested in addressing the needs of individuals affected by rare liver diseases. Our team consists of dedicated professionals with a deep understanding of rare diseases, pediatric care, and patient advocacy. While academic and professional credentials are not the sole basis of our suitability, our team's expertise and experience in the field enable us to approach the solution with comprehensive knowledge and a patient-centered perspective.

To ensure that our solution is well-aligned with the needs of the target population, we have taken proactive steps to engage and collaborate with the communities we aim to serve. We have established partnerships with patient advocacy groups, rare disease organizations, and healthcare providers specializing in liver diseases. These collaborations allow us to gather valuable insights, firsthand experiences, and expert input that inform the design and implementation of the Live Rare App.

We conduct regular focus groups, interviews, and surveys involving individuals affected by rare liver diseases, their caregivers, and healthcare providers. These interactions provide us with a direct understanding of their challenges, preferences, and unmet needs. By actively listening to their voices, we ensure that the solution reflects their priorities, addresses their concerns, and aligns with their agendas.

The design and implementation of the Live Rare App are meaningfully guided by the input, ideas, and agendas of the communities we serve. We have established a feedback loop where we regularly seek input from our target population throughout the development process. This includes seeking feedback on app features, usability, information content, and user experience. We also involve community representatives in our decision-making processes, ensuring that their perspectives are integrated into our solution's design and implementation.

Our commitment to community engagement extends beyond the development phase. We continue to collaborate with patient advocacy groups and rare disease organizations to ensure that ongoing updates, improvements, and enhancements of the Live Rare App align with the evolving needs of the community. By maintaining open lines of communication and actively involving the communities in decision-making, we ensure that our solution remains relevant, responsive, and beneficial to those we aim to serve.

Overall, our team's proximity to the communities we serve, combined with our collaborative approach and continuous engagement, positions us well to design and deliver a solution that truly addresses the unique needs of individuals affected by rare liver diseases.

The Live Rare App has evolved from a conceptual stage into a prototype, demonstrating tangible progress in its development. Here are the key elements that differentiate the solution as a prototype rather than a concept:

1. Framework and Design Model: The app has undergone the process of creating a framework, which outlines its structure and functionality. Additionally, a design model has been established, providing a visual representation of the app's user interface and interaction design.

2. Stakeholder Feedback: The solution has actively sought feedback and input from patients, caregivers, and other relevant stakeholders. This engagement ensures that the app is designed to address their specific needs and challenges, making it more than just an abstract concept.

3. Projected Budget: The Live Rare App has a projected budget in place, indicating a level of planning and consideration for resource allocation. This demonstrates a commitment to turning the idea into a tangible reality.

4. Prototype Development: The app has progressed beyond the conceptual stage and now has a design prototype in its earliest form. This prototype allows for design and validation of key features, user experience, and technical feasibility.

We are applying to the Prize because it presents an opportunity to accelerate the development and implementation of the Live Rare App, addressing specific barriers that we face. Here are the barriers we hope the Prize can help us overcome:

1. Financial Barriers: Developing and launching a comprehensive mobile health application requires significant financial resources. The Prize can provide funding that will enable us to enhance the app's features, conduct further research, and expand our reach to a larger user base. It will help us overcome financial constraints and ensure the sustainability of the project.

2. Technical Challenges: Building a robust and user-friendly app involves technical expertise and infrastructure. The Prize can offer technical support, mentorship, and access to relevant resources, helping us overcome technical barriers. This support will contribute to the refinement of the app's functionality, security, scalability, and interoperability.

3. Legal Considerations: Navigating legal and regulatory frameworks, such as data privacy and security regulations, can be complex and time-consuming. The Prize can provide legal guidance and support to ensure compliance with applicable laws and regulations, mitigating legal barriers and facilitating smooth implementation.

4. Cultural and Market Barriers: Rare liver diseases often face a lack of awareness, limited resources, and inadequate support systems. The Prize can help us overcome cultural and market barriers by providing a platform to showcase the app's potential and raise awareness about the importance of liver disease management. It can also facilitate networking and partnerships with stakeholders in the healthcare industry, enabling us to reach a wider audience and make a meaningful impact.

By addressing these specific financial, technical, legal, cultural, and market barriers, the Prize can significantly enhance our ability to deliver the Live Rare App effectively and make a positive difference in the lives of rare disease patients and their caregivers.

Our Team Lead, Royze Cachero, has a strong connection to the rare disease community, particularly the rare liver disease community. She have extensive experience working as a pediatric and rare liver disease lead, directly engaging with patients, caregivers, and healthcare providers in this field. Through her role, they have developed deep relationships with advocacy groups, patient organizations, and medical professionals specialized in rare liver diseases.

She actively participates in rare disease conferences, symposiums, and support group meetings, where she interact with patients and caregivers, listen to her experiences, and understand her needs and challenges. She regularly collaborate with leading experts and researchers in the field to stay updated on the latest advancements and best practices in rare liver disease management.

By being closely connected to the rare disease community, our Team Lead brings firsthand insights, empathy, and a patient-centered approach to the development of the Live Rare App. She are committed to ensuring that the solution is tailored to the specific needs of the community and addresses their unique challenges. The Team Lead actively seeks feedback, input, and guidance from community members throughout the design and implementation process, ensuring that the app is truly representative and impactful.

Our solution, the Live Rare App, is innovative and sustainable in several ways. Firstly, it addresses the specific needs of the rare liver disease community, which has been traditionally underserved in the health information technology space. By providing a comprehensive, patient-centric interface, our app revolutionizes the way patients and caregivers track, manage, and educate themselves about liver diseases.

One of the key innovations of our solution is the integration of tailored education and empowerment tools. Through personalized content and chatbot-like experiences, we educate patients on their diseases, clinical trials, therapies, and self-care strategies. This approach goes beyond generic information and provides targeted support to individual users, enhancing their understanding and engagement in their own healthcare journey.

Moreover, our app fosters stronger relationships between patients and healthcare providers. It facilitates effective communication and removes language, cultural, and technological barriers through a two-way translated communication platform. By promoting collaborative decision-making and mutual understanding, we aim to improve the quality of care and outcomes for rare liver disease patients.

In terms of sustainability, the Live Rare App is designed to be scalable and adaptable. While initially focused on rare liver diseases, our framework and infrastructure can be expanded to serve the broader rare disease community. This scalability allows us to catalyze positive impacts beyond our initial target population, providing valuable insights and resources to a wider range of patients and caregivers.

Additionally, by collecting and analyzing data through our app, we contribute to the advancement of research, clinical trials, and patient advocacy efforts. The rich dataset generated by our platform can inform policy decisions, drive innovation, and improve healthcare practices in the field of rare diseases. This potential for broader positive impacts positions us as catalysts for change in the market, driving innovation, collaboration, and improved patient outcomes.

Overall, the Live Rare App combines innovative features, personalized education, enhanced patient-provider communication, and scalability to transform the way rare liver diseases are managed. By leveraging technology and empowering patients, we aim to create a paradigm shift in the market, fostering improved care, engagement, and outcomes for the rare disease community as a whole.

Our impact goals for the next year and the next five years are centered around transforming the lives of rare liver disease patients and their caregivers. Our overarching objective is to improve their health outcomes, quality of life, and empowerment through the Live Rare App.

1. Next Year Impact Goals:

• Reach a significant number of rare liver disease patients and caregivers, aiming to have [specific number or percentage] of them actively using the Live Rare App.
• Enhance patient education and disease management by providing personalized content, resources, and tools to [specific number] of users.
• Foster stronger patient-provider relationships by facilitating effective communication and understanding between [specific number] of patients and healthcare providers.
• Collect valuable data and insights on rare liver diseases through the app, contributing to research and advocacy efforts.

To achieve these goals, we will focus on:

• Implementing targeted marketing and outreach strategies to raise awareness of the Live Rare App among the rare liver disease community.
• Continuously improving and expanding the app's features based on user feedback and evolving healthcare needs.
• Collaborating with healthcare organizations, patient advocacy groups, and research institutions to ensure the app aligns with the latest medical advancements and best practices.
• Conducting user engagement and satisfaction surveys to measure the app's impact and make data-driven improvements.

1. Five-Year Impact Goals:

• Establish the Live Rare App as a leading platform for rare liver disease management, with a substantial user base representing a significant percentage of the rare disease population.
• Enable widespread access to the app by partnering with healthcare providers, insurers, and patient organizations to promote its adoption and integration into care pathways.
• Contribute to improved health outcomes and reduced healthcare disparities among rare liver disease patients, evidenced by [specific metrics].
• Facilitate research collaborations and data sharing initiatives to accelerate the discovery of new treatments and interventions for rare liver diseases.
• Expand the app's reach to other rare disease communities, leveraging our scalable infrastructure and expertise.

To achieve these long-term impact goals, we will:

• Continuously innovate and enhance the Live Rare App to meet evolving user needs and technological advancements.
• Forge strategic partnerships and collaborations with stakeholders in the rare disease ecosystem to drive collective impact.
• Advocate for policy changes and increased support for rare disease research, care, and patient empowerment.
• Seek funding opportunities and grants to sustain the development, maintenance, and growth of the Live Rare App.

By pursuing these impact goals and implementing our strategic roadmap, we are committed to making a transformative difference in the lives of rare liver disease patients and caregivers, ultimately improving healthcare outcomes and empowering individuals in their healthcare journey.

We are measuring our progress toward our impact goals through a combination of qualitative and quantitative indicators. Here are a few specific indicators we are using:

1. App Usage and Adoption:

• Number of active users: We track the total number of individuals actively using the Live Rare App on a regular basis.
• User engagement metrics: We analyze user behavior within the app, including frequency of logins, time spent on the app, and the use of different features to gauge user engagement and satisfaction.
• User feedback and ratings: We collect user feedback through surveys, reviews, and ratings to assess their experience and identify areas for improvement.

1. Health Outcomes and Empowerment:

• Disease management indicators: We monitor specific health outcomes and improvements in symptom management reported by users, such as reduced hospitalizations, better medication adherence, and improved quality of life.
• Patient empowerment: We assess the level of patient empowerment through surveys and interviews, focusing on aspects like knowledge about their condition, confidence in making healthcare decisions, and active participation in their care.

1. Collaborations and Research Impact:

• Research partnerships: We track the number and scope of collaborations with research institutions, universities, and other organizations to measure the impact of the Live Rare App on advancing rare liver disease research.
• Publications and research outputs: We monitor the number of scientific publications, abstracts, and conference presentations resulting from research conducted using the data collected through the app.

1. User Reach and Diversity:

• Demographic data: We collect demographic information from app users to ensure our solution reaches a diverse population and to identify potential disparities in access and engagement.
• Geographic reach: We analyze the geographic distribution of app users to assess the reach of our solution across different regions and communities.

1. Partnerships and Funding:

• Number of strategic partnerships: We track the number of partnerships established with healthcare providers, patient advocacy groups, research institutions, and other stakeholders to measure the expansion of our network and collaborative efforts.
• Funding and grants: We monitor the amount and sources of funding secured to support the development, maintenance, and growth of the Live Rare App.

By regularly monitoring these indicators, we can evaluate our progress, identify areas for improvement, and demonstrate the impact of our solution on the rare liver disease community. This data-driven approach allows us to make informed decisions, refine our strategies, and effectively communicate the value and outcomes of the Live Rare App to our stakeholders and partners.

Our solution, the Live Rare App, is expected to have a significant impact on the problem of limited access to information, support, and self-management tools for rare liver disease patients. Here's how and why we expect our solution to make a difference:

1. Increased Awareness and Education:

• Activities: Through the app, we provide comprehensive and tailored education resources, including information about rare liver diseases, current clinical trials and therapies, and self-care strategies.
• Outputs: Users can access the patient education toolkit, receive personalized content, and engage in educational modules.
• Outcomes: By increasing awareness and knowledge, patients and caregivers can make informed decisions, actively participate in their healthcare, and better understand the management of rare liver diseases.

1. Enhanced Patient-Clinician Relationships:

• Activities: The app facilitates communication and collaboration between patients and healthcare providers, allowing for information sharing, tracking of symptoms and medications, and forum discussions.
• Outputs: Users can engage in two-way translated communication, track their health data, and participate in patient-provider input forums.
• Outcomes: Stronger relationships and improved communication between patients and clinicians lead to better understanding, trust, and shared decision-making, resulting in improved healthcare outcomes and satisfaction.

1. Empowered Self-Management:

• Activities: The app includes self-management tools such as symptom and medication trackers, wellness and prevention resources, and journaling capabilities.
• Outputs: Users can track their symptoms, medications, daily activities, and access personalized coaching and support.
• Outcomes: Empowered with self-management tools, patients can actively monitor their health, identify patterns, make lifestyle adjustments, and effectively manage their condition, leading to improved overall well-being and quality of life.

1. Data Collection for Research and Advocacy:

• Activities: The app collects anonymous data on symptoms, medications, and patient experiences, which can be used for research, clinical trials, and advocacy efforts.
• Outputs: Data is securely stored in a cloud-based rare liver disease database and registry.
• Outcomes: The aggregated data enables researchers to gain insights into rare liver diseases, inform treatment approaches, identify trends, and advocate for better resources and support for the rare disease community.

By combining these activities, outputs, and outcomes, we expect the Live Rare App to create a positive and transformative impact on the rare liver disease community. Through increased awareness, empowered self-management, improved patient-clinician relationships, and data-driven research, we aim to enhance the lives of patients, provide them with the support they need, and contribute to advancements in rare liver disease understanding and care.

The core technology that powers the Live Rare App is a comprehensive mobile application developed for both iOS and Android platforms, as well as a website platform. The app utilizes a range of technologies to deliver its features and functionalities, including:

1. Mobile Application Development: The app is built using modern programming languages such as Swift for iOS and Java/Kotlin for Android. These languages allow for efficient and native app development, ensuring optimal performance and user experience on mobile devices.

2. Cloud-Based Infrastructure: The app leverages cloud computing infrastructure, which provides scalability, reliability, and data storage capabilities. This infrastructure enables secure data storage, access, and synchronization across devices, ensuring that users can access their information anytime, anywhere.

3. Data Management and Analytics: The app employs robust data management systems and analytics tools to handle user data, track symptoms, medications, and other health-related information. These technologies enable efficient data collection, storage, and analysis, supporting personalized coaching, insights, and research purposes.

4. Natural Language Processing (NLP): The app utilizes NLP algorithms and techniques to enable two-way translated communication between patients and healthcare providers. NLP helps facilitate effective communication by translating messages in real-time, breaking down language barriers, and ensuring accurate understanding between different languages.

5. Machine Learning and Personalization: The app incorporates machine learning algorithms to provide personalized coaching, recommendations, and content based on user data, preferences, and behavior. Machine learning enables the app to adapt and tailor its offerings to the unique needs and circumstances of each user.

6. Secure Data Protection: The app implements industry-standard security measures, including encryption protocols, user authentication, and access controls, to ensure the privacy and protection of sensitive user information. This technology safeguards user data from unauthorized access, ensuring confidentiality and compliance with data protection regulations.

By leveraging these core technologies, the Live Rare App delivers a user-friendly, secure, and feature-rich platform that empowers rare liver disease patients and caregivers to track their health, access educational resources, engage with healthcare providers, and contribute to research efforts in the field.

Our solution team consists of a Program Lead, a Coordinator, and additional team members. Here is a breakdown of the team composition:

Full-time staff:

• Program Lead: 1
• Coordinator: 1

Our team has been working on the Live Rare App solution for 1 year.

At the Global Liver Institute, we are dedicated to incorporating diversity, equity, and inclusivity into our work. As an organization, we understand the value of diverse perspectives and experiences in driving innovation and addressing complex challenges.

Our leadership team is committed to promoting diversity at all levels of the organization. We strive to ensure representation from various backgrounds, cultures, and identities, recognizing that this diversity enhances our ability to understand and address the unique needs of the communities we serve. We actively seek out individuals from underrepresented groups and prioritize inclusivity in our recruitment and selection processes.

To foster an inclusive work environment, we promote equal opportunities for professional growth and advancement for all team members. We provide ongoing training and education on diversity, equity, and inclusion topics to raise awareness and enhance cultural competency within our organization. We also prioritize creating a safe and respectful space where everyone feels valued, supported, and empowered to contribute their unique perspectives.

In our work with external stakeholders, we are committed to engaging diverse communities, including patients, caregivers, healthcare providers, and advocacy groups. We actively seek their input and collaborate with them to ensure that our solutions are inclusive and responsive to their needs. We believe that co-creation and partnership with diverse stakeholders are crucial in driving meaningful impact and promoting equity in healthcare.

We recognize that our journey towards diversity, equity, and inclusivity is ongoing. We regularly assess our practices, policies, and programs to identify areas for improvement and take proactive measures to address any disparities or barriers that may exist. Through our commitment to diversity, equity, and inclusion, we aim to build a more equitable healthcare landscape and empower all individuals affected by liver diseases to live healthier and fulfilling lives.

At the Global Liver Institute, our business model is centered around providing value to the populations we serve, which includes patients, caregivers, healthcare providers, and the broader liver disease community. We offer a range of products and services aimed at improving outcomes, promoting education, and empowering individuals affected by liver diseases.

Our primary products and services include:

1. Patient Education and Support: We develop educational resources, materials, and toolkits to empower patients and their caregivers with knowledge about liver diseases, treatment options, and self-care strategies. We provide online platforms, webinars, and workshops to facilitate peer support and knowledge sharing among patients.

2. Advocacy and Policy: We advocate for policy changes at the local, national, and international levels to improve access to quality care, research funding, and support systems for liver disease patients. We engage with policymakers, healthcare providers, and other stakeholders to raise awareness and drive meaningful change.

3. Research and Innovation: We collaborate with researchers, academic institutions, and industry partners to support and promote liver disease research. We facilitate partnerships that foster innovation in diagnostics, treatments, and healthcare delivery models to improve patient outcomes and quality of life.

4. Capacity Building and Training: We offer training programs and resources for healthcare providers, equipping them with the knowledge and skills needed to deliver optimal care to liver disease patients. We also provide capacity-building initiatives for patient advocacy groups to enhance their effectiveness in advocating for their communities.

To sustain our operations and ensure the long-term viability of our impact, we employ a diversified funding model. Our revenue streams include grants, sponsorships, partnerships with pharmaceutical companies and healthcare organizations, individual donations, and fundraising activities. We also explore opportunities for social enterprise initiatives and fee-for-service models to generate additional income while staying true to our mission and values.

Overall, our business model is designed to provide valuable resources, support, and advocacy for the liver disease community while engaging various stakeholders and securing the necessary resources to achieve our mission.

At the Global Liver Institute, we have a comprehensive plan for achieving financial sustainability to support our mission and continue delivering impact in the long term. Our approach involves a combination of revenue streams and strategic partnerships:

1. Donations and Grants: We actively seek sustained donations and grants from individuals, philanthropic organizations, and corporate entities who share our vision and want to contribute to improving liver disease outcomes. We cultivate relationships with potential donors and maintain transparency in our operations to inspire trust and attract ongoing support.

2. Partnerships and Sponsorships: We collaborate with pharmaceutical companies, healthcare organizations, and other relevant stakeholders to establish strategic partnerships and secure sponsorships. These partnerships can involve joint initiatives, research collaborations, educational programs, or fundraising campaigns, providing a mutually beneficial relationship that supports our work financially

3. Social Enterprise Initiatives: We develop and implement social enterprise initiatives that align with our mission and generate revenue. This can involve creating and selling innovative products, such as educational materials, awareness campaigns, or digital tools, to generate income while promoting liver disease awareness and education.

4. Fundraising Activities: We organize fundraising events, campaigns, and initiatives to engage our supporters and the wider community in our mission. These activities can include benefit concerts, charity runs, online crowdfunding campaigns, or community-driven fundraising efforts.

5. Government Contracts and Funding: We actively pursue service contracts with governments and healthcare institutions to provide specialized services, training, or consultation in the field of liver disease management. We also explore opportunities for securing government funding for specific programs or research initiatives aligned with public health priorities.

By diversifying our revenue streams and maintaining a sustainable balance between donations, partnerships, and fundraising activities, we aim to create a financially resilient organization. We regularly review and assess the effectiveness of our revenue generation strategies, adapt to changing market dynamics, and explore new opportunities for growth and sustainability.

1. Grants and Funding: The Global Liver Institute has successfully secured grants from reputable organizations and foundations that support their mission and initiatives. These grants can provide essential funding for specific projects, research, or operational expenses.

2. Partnerships and Sponsorships: The institute has formed strategic partnerships with pharmaceutical companies, healthcare organizations, and other relevant stakeholders. These partnerships may involve financial support, in-kind contributions, or joint initiatives that generate revenue and advance the organization's goals.

3. Social Enterprise Ventures: The institute has launched social enterprise initiatives that generate income while promoting their mission. This could include the development and sale of educational materials, merchandise, or other innovative products that raise awareness and contribute to financial sustainability.

4. Fundraising Success: The Global Liver Institute has demonstrated success in fundraising activities, such as organizing charity events, crowdfunding campaigns, or engaging the community in grassroots fundraising efforts. These initiatives generate financial support from individuals, businesses, and the wider community.